Paradigm Biocapital Advisors LP

13F Holdings History for LENZ Therapeutics, Inc. - Common Stock, $0.00001 par value per share (LENZ)

Symbol: LENZ on Nasdaq
Investment type: Equity / Common Stock, $0.00001 par value per share
Latest Disclosed Ownership: 1.07M shares
Security Ownership: 3.8%

Shares, Excluding Options vs Price

Value, Excluding Options

Paradigm BioCapital Advisors LP ownership in LENZ Therapeutics, Inc. Common Stock, $0.00001 par value per share (LENZ)

2025-11-14 - Paradigm BioCapital Advisors LP has filed an SCHEDULE 13G/A form with the Securities and Exchange Commission (SEC) disclosing ownership of 1.07M shares of LENZ Therapeutics, Inc. Common Stock, $0.00001 par value per share (LENZ). This represents 3.8% percent ownership of the company. In their previous filing dated 2025-03-27, Paradigm Biocapital Advisors LP had reported owning 1.42M shares, indicating a decrease of -24.4% percent.

Reporting Name	Ownership %	Change	Value $	Shares owned	Change	Activity %	Price	Form	Report date	Filed at
Paradigm BioCapital Advisors LP	3.8%	-28%	$50M	1.07M	-346,371	-24.4%	$46.58	13G/A	9/30/2025	14 Nov 2025 16:32:28
Paradigm BioCapital Advisors LP	5.2%		$26.3M	1.42M			$18.54	13G	3/20/2025	27 Mar 2025 16:21:15

Holdings date	Weight	Change	Value $	Shares	Change	Activity %	Price	All Holders
9/30/2025	1.48%	-0.89%	$50M	1.07M	-643,605	-37.5%	$46.58	Q3 2025
6/30/2025	2.15%	+0.26%	$50.3M	1.72M	+205,134	+13.6%	$29.31	Q2 2025
3/31/2025	1.79%	+0.88%	$38.9M	1.51M	+741,477		$25.71	Q1 2025
12/31/2024	0.77%	+0.77%	$22.2M	770K	+770,455	NEW	$28.87	Q4 2024

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.